A DOT 5-panel drug test is a federally mandated urine drug screening that checks for five classes of substances: marijuana, cocaine, opiates, amphetamines, and phencyclidine (PCP). It’s required by the U.S. Department of Transportation for anyone working in a safety-sensitive transportation role, covering roughly 6.5 million employees across the country. Unlike employer-designed drug tests that can vary in what they screen for, the DOT version follows a strict set of federal rules under 49 CFR Part 40, meaning every test uses the same substances, the same procedures, and the same cutoff levels regardless of where you take it.
The Five Drug Categories Tested
The “5-panel” label refers to five broad drug classes, but within those classes, labs screen for more specific substances than you might expect. Here’s what each panel actually covers:
- Marijuana: The lab looks for THC metabolites in your urine, not THC itself. The initial screening cutoff is 50 ng/mL, but if that comes back positive, a confirmatory test uses a much lower threshold of 15 ng/mL. This matters because even infrequent use can trigger the confirmatory test once the initial screen flags your sample.
- Cocaine: The test detects a cocaine byproduct your body produces after exposure. The initial cutoff is 150 ng/mL, dropping to 100 ng/mL at confirmation.
- Opiates: This is the broadest panel. It screens separately for codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and heroin (detected through a heroin-specific metabolite). Cutoff levels vary. Codeine and morphine have a relatively high initial threshold of 2,000 ng/mL, while hydrocodone and its relatives are flagged at 300 ng/mL, and oxycodone compounds at 100 ng/mL. The heroin marker has the lowest cutoff at just 10 ng/mL.
- Amphetamines: This panel catches amphetamine, methamphetamine, MDMA (ecstasy), and MDA. The initial screen threshold is 500 ng/mL for all of these, with confirmatory testing at 250 ng/mL.
- PCP (phencyclidine): Screened at 25 ng/mL for both initial and confirmatory tests.
If your initial screen comes back negative, the process stops there. A positive initial screen automatically triggers a second, more precise confirmatory test on the same sample. Only if that confirmatory test also comes back positive does the result move forward for review.
Who Has to Take It
The DOT 5-panel test applies to safety-sensitive employees in six transportation sectors: aviation, trucking (including school bus drivers and certain limousine and van operators), railroads, mass transit, pipelines, and maritime operations. Each sector is overseen by a different federal agency, from the Federal Aviation Administration to the U.S. Coast Guard, but all follow the same core testing rules.
If your job involves operating a commercial vehicle, flying an aircraft, dispatching trains, maintaining pipelines, or performing any function where impairment could endanger the public, you fall under these requirements. The test is not optional for employers in these industries. They are legally required to administer it under specific circumstances.
When Testing Is Required
DOT drug testing isn’t a one-time event. It happens at multiple points throughout your career in a safety-sensitive role:
- Pre-employment: Your employer must receive a negative drug test result before you’re allowed to perform safety-sensitive duties. No negative result, no start date.
- Random testing: Employees are selected randomly throughout the year. You won’t get advance notice, and refusal counts the same as a positive result.
- Post-accident: Drug and alcohol testing is required after any crash involving a fatality. It’s also required after crashes involving bodily injury or vehicle damage severe enough to require a tow, but only if the driver received a citation.
- Reasonable suspicion: If a trained supervisor observes signs of impairment, they can order immediate testing. Employers are required to train supervisors specifically on recognizing symptoms of drug or alcohol use.
- Return-to-duty: Required after any positive test or testing violation, once you’ve completed the full return-to-duty process.
- Follow-up: After returning to duty, you’ll face a minimum of six directly observed tests over the next 12 months. A substance abuse professional can extend this follow-up period for up to four additional years.
How the Test Works
DOT testing has traditionally been urine-only, but as of December 2024, oral fluid (saliva) testing is also permitted under updated federal rules. Your employer or their testing service will determine which collection method is used.
For urine testing, you provide a sample at an approved collection site under controlled conditions designed to prevent tampering. The sample is split into two containers, sealed, and sent to a certified laboratory. The lab runs the initial immunoassay screen first. If everything comes back below the cutoff levels, the result is reported as negative.
If any substance triggers a positive on the initial screen, the lab performs a confirmatory test using more precise technology on the same sample. This two-step process exists to eliminate false positives from common foods, supplements, or over-the-counter medications that might cross-react on the initial screen.
The Medical Review Officer’s Role
One feature that sets DOT testing apart from standard employer drug screens is the Medical Review Officer, or MRO. Every positive confirmatory result goes to an MRO before it reaches your employer. The MRO is a licensed physician trained specifically in DOT drug testing procedures.
The MRO contacts you directly to discuss the result. If you have a legitimate prescription for a medication that caused the positive, such as a prescribed opioid painkiller or an amphetamine-based ADHD medication, the MRO evaluates whether that prescription explains the result. If it does, the MRO can report the test as negative to your employer. You never have to disclose your specific medication to your employer in this process. The MRO simply reports the final determination.
What Happens After a Positive Result
A verified positive result, or a refusal to test, immediately removes you from safety-sensitive duties. You cannot drive a commercial vehicle, operate equipment, or perform any regulated function until you complete the return-to-duty process.
Your employer is required to provide you with a list of DOT-qualified Substance Abuse Professionals, known as SAPs. You select one and undergo an initial evaluation, after which the SAP recommends a course of education or treatment. The specifics vary depending on your situation. It could range from an educational program to inpatient treatment.
Once you complete whatever the SAP recommended, you return for a follow-up evaluation. If the SAP determines you’ve complied with the treatment plan, they clear you for a return-to-duty test. This test is directly observed, meaning a same-gender collector watches the sample collection. Only a negative result on this test allows you to resume safety-sensitive work. After that, the follow-up testing period begins, with at least six observed tests over the next year and the possibility of continued testing for up to five years total.
How DOT Testing Differs From Standard Drug Tests
Many private employers use 5-panel drug tests that look similar on paper, but DOT testing is a fundamentally different process. Private employers can choose their own cutoff levels, add substances to the panel, skip the MRO review, or use rapid point-of-care tests as final results. None of that is permitted under DOT rules.
DOT testing also feeds into the FMCSA Drug and Alcohol Clearinghouse, a federal database that tracks violations across the trucking industry. If you test positive with one employer, that record follows you. A new employer is required to query the Clearinghouse before hiring you for a safety-sensitive position, so a violation can’t simply be left off a job application. The record stays until you complete the full return-to-duty process and all follow-up requirements.